Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axillary Reverse Mapping with ICG in Breast Cancer
NCT02994225Completed
- Sponsor
- Gustave Roussy
- Start
- Mar 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Gustave Roussy. Primary endpoint: Rate of identification at 30 days. Started Mar 2017; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02994225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02994225.